1. 3/20/2008 7:26:04 AM, B, Muskogee Why was a 14 year old driving at night..for that matter, at all? This is terrible and parents should be held in account here.
Micromet’s success hinges on its BiTE antibody technology platform, which is designed to direct the body’s cell-destroying T cells against tumor cells. It may be on to something.
Here are highlights from the August issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit www.HealthLetter.MayoClinic.com or call toll-free for subscription information, 800-333-9037,
With the continued aging of the population and the growing epidemic of Alzheimers, early detection of the disease is crucial for risk assessment, testing new therapies, and eventual early intervention with better drugs, once they are developed. Four studies reported today at the Alzheimers Associations 2008 International Conference on Alzheimers Disease (ICAD 2008) in Chicago bring us closer to
View comments
Hide comments
